GV1001 Subcutaneous(SC) for the Treatment of Moderate Alzheimer's Disease (AD)
Clinical trial NCT03959553 · WITHDRAWN
Trial details
- NCT number
- NCT03959553
- Sponsor
- GemVax & Kael
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-01
- Primary completion
- 2021-08-31
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.